| cell matrix adhesion | GO:0007160 | 68 | 0.446 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.407 | |
| regulation of cell migration | GO:0030334 | 219 | 0.366 | Rat |
| blood circulation | GO:0008015 | 195 | 0.326 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.298 | Human Zebrafish |
| muscle contraction | GO:0006936 | 101 | 0.277 | |
| regionalization | GO:0003002 | 337 | 0.231 | |
| regulation of system process | GO:0044057 | 200 | 0.227 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.226 | |
| heart contraction | GO:0060047 | 93 | 0.203 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.187 | |
| regulation of cell motility | GO:2000145 | 236 | 0.184 | Rat |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.184 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.182 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.179 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.172 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.168 | |
| circulatory system process | GO:0003013 | 197 | 0.167 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.164 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.158 | |
| neuronal action potential | GO:0019228 | 54 | 0.158 | |
| striated muscle contraction | GO:0006941 | 45 | 0.158 | |
| cell adhesion | GO:0007155 | 329 | 0.157 | Mouse |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.157 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.157 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.152 | Rat |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.152 | |
| mapk cascade | GO:0000165 | 281 | 0.147 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.146 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.143 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.142 | |
| angiogenesis | GO:0001525 | 201 | 0.140 | Human Zebrafish |
| gtp metabolic process | GO:0046039 | 144 | 0.138 | |
| ossification | GO:0001503 | 216 | 0.137 | |
| response to growth factor | GO:0070848 | 198 | 0.132 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.131 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.129 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.123 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.122 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.121 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.116 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.113 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.111 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.111 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.111 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.109 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.107 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.105 | |
| nephron development | GO:0072006 | 109 | 0.105 | |
| kidney development | GO:0001822 | 213 | 0.105 | |
| tissue homeostasis | GO:0001894 | 115 | 0.103 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.103 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.102 | |
| immune effector process | GO:0002252 | 321 | 0.101 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.099 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.099 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.099 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.098 | |
| muscle tissue development | GO:0060537 | 308 | 0.098 | |
| cell junction organization | GO:0034330 | 77 | 0.097 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.095 | |
| developmental maturation | GO:0021700 | 193 | 0.095 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.092 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.092 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.092 | |
| renal system development | GO:0072001 | 225 | 0.091 | |
| neuron projection guidance | GO:0097485 | 141 | 0.091 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.090 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.089 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.088 | |
| gtp catabolic process | GO:0006184 | 143 | 0.088 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.087 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.086 | |
| extracellular structure organization | GO:0043062 | 148 | 0.085 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.084 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.081 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.080 | |
| cell junction assembly | GO:0034329 | 52 | 0.080 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.078 | |
| forebrain development | GO:0030900 | 302 | 0.078 | |
| action potential | GO:0001508 | 78 | 0.078 | |
| bone development | GO:0060348 | 120 | 0.078 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.078 | Rat |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.077 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.076 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.075 | |
| synaptic transmission | GO:0007268 | 329 | 0.075 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.074 | |
| leukocyte migration | GO:0050900 | 124 | 0.074 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.073 | |
| protein catabolic process | GO:0030163 | 221 | 0.072 | |
| muscle system process | GO:0003012 | 141 | 0.072 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.070 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.070 | |
| heart trabecula formation | GO:0060347 | 14 | 0.068 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.068 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.068 | |
| t cell activation | GO:0042110 | 289 | 0.067 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.067 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.066 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.066 | |
| respiratory tube development | GO:0030323 | 167 | 0.066 | |
| protein localization to membrane | GO:0072657 | 108 | 0.066 | |
| transmembrane transport | GO:0055085 | 412 | 0.066 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.064 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.064 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.063 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.063 | |
| cardiac septum development | GO:0003279 | 59 | 0.062 | |
| axonogenesis | GO:0007409 | 274 | 0.061 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.061 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.060 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.060 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.060 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.059 | |
| defense response to other organism | GO:0098542 | 197 | 0.059 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.059 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.059 | |
| regulation of ossification | GO:0030278 | 112 | 0.058 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.057 | |
| endothelium development | GO:0003158 | 45 | 0.057 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.057 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.057 | |
| chemotaxis | GO:0006935 | 247 | 0.057 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.056 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.056 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.055 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.055 | |
| trunk neural crest cell migration | GO:0036484 | 4 | 0.055 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.055 | |
| respiratory system development | GO:0060541 | 190 | 0.055 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.054 | |
| heart process | GO:0003015 | 94 | 0.053 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.053 | |
| compartment pattern specification | GO:0007386 | 4 | 0.053 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.052 | |
| cell division | GO:0051301 | 120 | 0.052 | |
| cation transport | GO:0006812 | 399 | 0.051 | |
| wound healing | GO:0042060 | 157 | 0.051 | Human |
| cartilage development | GO:0051216 | 140 | 0.051 | |
| regulation of neuron death | GO:1901214 | 134 | 0.051 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.051 | |
| bone resorption | GO:0045453 | 38 | 0.050 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.050 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.050 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.050 | |
| skeletal system development | GO:0001501 | 356 | 0.049 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.049 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.049 | |
| axon ensheathment | GO:0008366 | 76 | 0.048 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.048 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.048 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.048 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.048 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.048 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.047 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.047 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.047 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.047 | |
| heart morphogenesis | GO:0003007 | 178 | 0.046 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.046 | |
| adherens junction organization | GO:0034332 | 28 | 0.046 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.045 | |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.045 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.045 | |
| ureteric bud development | GO:0001657 | 94 | 0.044 | |
| lung development | GO:0030324 | 164 | 0.044 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.044 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.044 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.043 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.043 | |
| organelle assembly | GO:0070925 | 177 | 0.043 | |
| substrate adhesion dependent cell spreading | GO:0034446 | 30 | 0.043 | |
| organ growth | GO:0035265 | 117 | 0.043 | |
| organelle fission | GO:0048285 | 170 | 0.042 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.042 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.042 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.042 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.042 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.041 | |
| bone morphogenesis | GO:0060349 | 78 | 0.041 | |
| cell migration involved in kidney development | GO:0035787 | 3 | 0.041 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.041 | |
| endocytosis | GO:0006897 | 168 | 0.041 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.041 | |
| response to acid chemical | GO:0001101 | 111 | 0.041 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.041 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 1 | 0.040 | |
| cardiac chamber development | GO:0003205 | 108 | 0.040 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.040 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.040 | |
| axon guidance | GO:0007411 | 141 | 0.040 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.039 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.039 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.039 | |
| positive regulation of catecholamine secretion | GO:0033605 | 2 | 0.039 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.039 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.039 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.039 | |
| camera type eye development | GO:0043010 | 266 | 0.039 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.039 | |
| limb development | GO:0060173 | 166 | 0.038 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.038 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.038 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.038 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.038 | |
| ear morphogenesis | GO:0042471 | 118 | 0.038 | |
| morphogenesis of an endothelium | GO:0003159 | 2 | 0.038 | |
| regulation of binding | GO:0051098 | 111 | 0.038 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.038 | |
| cerebral cortex development | GO:0021987 | 86 | 0.038 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.037 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.037 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.037 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.037 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.036 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.036 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.036 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.036 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.036 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.036 | |
| pallium development | GO:0021543 | 120 | 0.036 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.036 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.036 | |
| actin filament organization | GO:0007015 | 113 | 0.035 | |
| germ cell development | GO:0007281 | 185 | 0.035 | |
| nuclear division | GO:0000280 | 158 | 0.035 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.035 | |
| mesoderm development | GO:0007498 | 100 | 0.035 | |
| chondrocyte development | GO:0002063 | 24 | 0.035 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.035 | |
| membrane organization | GO:0061024 | 245 | 0.035 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.034 | |
| striated muscle cell development | GO:0055002 | 125 | 0.034 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.034 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.034 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.034 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.034 | |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 1 | 0.034 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.034 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.034 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.033 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.033 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.033 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.033 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.033 | |
| oviduct development | GO:0060066 | 3 | 0.033 | |
| acetylcholine transport | GO:0015870 | 2 | 0.033 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.032 | |
| endothelial cell migration | GO:0043542 | 44 | 0.032 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.032 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.032 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.032 | |
| digestive system development | GO:0055123 | 200 | 0.031 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.031 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.031 | |
| cell adhesion mediated by integrin | GO:0033627 | 18 | 0.031 | |
| muscle cell development | GO:0055001 | 133 | 0.031 | |
| myotube differentiation | GO:0014902 | 105 | 0.031 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.031 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.031 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.031 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.031 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.031 | |
| positive regulation of lens epithelial cell proliferation | GO:2001111 | 1 | 0.030 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.030 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.030 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.030 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.030 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.030 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.030 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.030 | |
| regulation of bone resorption | GO:0045124 | 24 | 0.030 | |
| connective tissue development | GO:0061448 | 179 | 0.030 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.029 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.029 | |
| calcium ion transport | GO:0006816 | 159 | 0.029 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.029 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.029 | |
| response to peptide hormone | GO:0043434 | 127 | 0.029 | |
| vasodilation | GO:0042311 | 28 | 0.029 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.029 | |
| cell cell junction organization | GO:0045216 | 72 | 0.029 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.028 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.028 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.028 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.028 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.028 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.028 | |
| milk ejection | GO:0060156 | 1 | 0.028 | |
| male gamete generation | GO:0048232 | 285 | 0.028 | |
| norepinephrine transport | GO:0015874 | 2 | 0.028 | |
| regulation of extracellular matrix assembly | GO:1901201 | 2 | 0.028 | |
| rhythmic process | GO:0048511 | 174 | 0.028 | |
| metanephric glomerular basement membrane development | GO:0072274 | 1 | 0.028 | |
| appendage development | GO:0048736 | 166 | 0.027 | |
| nuclear transport | GO:0051169 | 139 | 0.027 | |
| regulation of cell shape | GO:0008360 | 39 | 0.027 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.027 | |
| spermatogenesis | GO:0007283 | 284 | 0.027 | |
| odontogenesis | GO:0042476 | 78 | 0.026 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.026 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.026 | |
| regulation of cell activation | GO:0050865 | 289 | 0.026 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.026 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.026 | |
| cell chemotaxis | GO:0060326 | 81 | 0.026 | |
| cellular response to lipid | GO:0071396 | 145 | 0.026 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.026 | |
| cation homeostasis | GO:0055080 | 212 | 0.026 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.025 | |
| lung alveolus development | GO:0048286 | 45 | 0.025 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.025 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.025 | |
| response to oxidative stress | GO:0006979 | 123 | 0.025 | |
| positive regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014718 | 2 | 0.025 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.025 | |
| placenta development | GO:0001890 | 140 | 0.025 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.025 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.025 | |
| regulation of protein binding | GO:0043393 | 60 | 0.025 | |
| endothelial cell development | GO:0001885 | 20 | 0.025 | |
| limb morphogenesis | GO:0035108 | 149 | 0.025 | |
| actin filament based movement | GO:0030048 | 23 | 0.025 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.025 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.025 | |
| embryonic placenta development | GO:0001892 | 98 | 0.024 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.024 | |
| response to inorganic substance | GO:0010035 | 96 | 0.024 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.024 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.024 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.024 | |
| cardiac conduction system development | GO:0003161 | 12 | 0.024 | |
| myosin filament organization | GO:0031033 | 3 | 0.024 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.024 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 9 | 0.024 | |
| artery development | GO:0060840 | 53 | 0.024 | |
| termination of rna polymerase i transcription | GO:0006363 | 2 | 0.024 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.024 | |
| acetate ester transport | GO:1901374 | 2 | 0.024 | |
| intracellular protein transport | GO:0006886 | 204 | 0.024 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.024 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.024 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.024 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.023 | |
| chromosome segregation | GO:0007059 | 48 | 0.023 | |
| notochord development | GO:0030903 | 20 | 0.023 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.023 | |
| ascending aorta morphogenesis | GO:0035910 | 3 | 0.023 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.023 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.023 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.023 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.023 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.023 | |
| granulocyte migration | GO:0097530 | 43 | 0.023 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.023 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.023 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.023 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.022 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.022 | |
| prostate gland morphogenetic growth | GO:0060737 | 4 | 0.022 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.022 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.022 | |
| microglia development | GO:0014005 | 2 | 0.022 | |
| metanephric mesangial cell differentiation | GO:0072209 | 1 | 0.022 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.022 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.022 | |
| stem cell development | GO:0048864 | 219 | 0.022 | |
| protein import | GO:0017038 | 101 | 0.022 | |
| cell maturation | GO:0048469 | 127 | 0.022 | |
| trabecula formation | GO:0060343 | 24 | 0.022 | |
| detection of stimulus | GO:0051606 | 84 | 0.022 | |
| multicellular organism growth | GO:0035264 | 161 | 0.022 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.022 | |
| muscle fiber development | GO:0048747 | 76 | 0.022 | |
| maintenance of location | GO:0051235 | 89 | 0.022 | |
| septum primum development | GO:0003284 | 4 | 0.022 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.022 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.022 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.021 | |
| lamellipodium organization | GO:0097581 | 29 | 0.021 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.021 | |
| phagocytosis | GO:0006909 | 66 | 0.021 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.021 | |
| regulation of lamellipodium assembly | GO:0010591 | 3 | 0.021 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.021 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.021 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.021 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.021 | |
| basement membrane assembly | GO:0070831 | 2 | 0.021 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.021 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.021 | |
| myelination | GO:0042552 | 74 | 0.021 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.020 | |
| regulation of endothelial cell differentiation | GO:0045601 | 10 | 0.020 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.020 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.020 | |
| ear development | GO:0043583 | 200 | 0.020 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.020 | |
| epithelial cell migration | GO:0010631 | 63 | 0.020 | |
| ascending aorta development | GO:0035905 | 3 | 0.020 | |
| regulation of vasculogenesis | GO:2001212 | 9 | 0.020 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.020 | |
| digestive tract development | GO:0048565 | 190 | 0.020 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.020 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.020 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.020 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.020 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.020 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.020 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.020 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.020 | |
| kidney epithelium development | GO:0072073 | 121 | 0.020 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.019 | |
| regulation of protein stability | GO:0031647 | 52 | 0.019 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.019 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.019 | |
| female gamete generation | GO:0007292 | 74 | 0.019 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.019 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.019 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.019 | |
| cellular homeostasis | GO:0019725 | 240 | 0.019 | |
| endodermal digestive tract morphogenesis | GO:0061031 | 4 | 0.019 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.019 | |
| plasma membrane organization | GO:0007009 | 90 | 0.019 | |
| extracellular matrix assembly | GO:0085029 | 12 | 0.019 | |
| blood vessel lumenization | GO:0072554 | 2 | 0.019 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.018 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.018 | |
| ventricular trabecula myocardium morphogenesis | GO:0003222 | 11 | 0.018 | |
| positive regulation of bone resorption | GO:0045780 | 13 | 0.018 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.018 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.018 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.018 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.018 | |
| epithelial cell development | GO:0002064 | 159 | 0.018 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.018 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.018 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.018 | |
| telencephalon development | GO:0021537 | 186 | 0.018 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.018 | |
| oocyte construction | GO:0007308 | 2 | 0.018 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.018 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.018 | |
| inflammatory response | GO:0006954 | 244 | 0.018 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.018 | |
| vegf activated neuropilin signaling pathway | GO:0038190 | 2 | 0.018 | |
| regulation of action potential | GO:0098900 | 4 | 0.018 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.018 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.018 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.018 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.017 | |
| neuron death | GO:0070997 | 154 | 0.017 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.017 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.017 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.017 | |
| response to nutrient levels | GO:0031667 | 109 | 0.017 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.017 | |
| response to insulin | GO:0032868 | 100 | 0.017 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.017 | |
| negative regulation of cartilage development | GO:0061037 | 17 | 0.017 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.017 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.017 | |
| adaptive immune response | GO:0002250 | 155 | 0.017 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.017 | |
| epidermis development | GO:0008544 | 187 | 0.017 | |
| urogenital system development | GO:0001655 | 261 | 0.017 | |
| negative regulation of b cell receptor signaling pathway | GO:0050859 | 4 | 0.017 | |
| retina vasculature morphogenesis in camera type eye | GO:0061299 | 10 | 0.017 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.017 | |
| protein import into nucleus | GO:0006606 | 95 | 0.017 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.017 | |
| regulation of secretion | GO:0051046 | 274 | 0.017 | |
| response to peptide | GO:1901652 | 136 | 0.017 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.017 | |
| gonad development | GO:0008406 | 141 | 0.017 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.016 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.016 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.016 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 1 | 0.016 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.016 | |
| myosin filament assembly | GO:0031034 | 2 | 0.016 | |
| neurotransmitter secretion | GO:0007269 | 62 | 0.016 | |
